Glass Jacobson Investment Advisors’s NeoGenomics NEO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-258
Closed -$4.25K 737
2025
Q1
$4.25K Hold
258
﹤0.01% 682
2024
Q4
$4.25K Hold
258
﹤0.01% 682
2024
Q3
$3.81K Hold
258
﹤0.01% 650
2024
Q2
$3.58K Hold
258
﹤0.01% 638
2024
Q1
$4.06K Hold
258
﹤0.01% 635
2023
Q4
$4.17K Hold
258
﹤0.01% 607
2023
Q3
$3.17K Hold
258
﹤0.01% 597
2023
Q2
$4.15K Buy
+258
New +$4.25K ﹤0.01% 591
2022
Q4
$2.38K Buy
+258
New +$2.4K ﹤0.01% 657

Other funds holding NEO

Glass Jacobson Investment Advisors's NEO Position: Q2 2025 in Review

Glass Jacobson Investment Advisors sold out of NeoGenomics (NEO) in Q2 2025, closing a stake of 258 shares — an estimated $4.25K sold.

Glass Jacobson Investment Advisors first reported a position in NEO in Q4 2022 and held it in 9 quarters. The position peaked at $4.25K in Q1 2025. 274 funds tracked by Wall St. Rank hold NEO as of Q2 2025.

  • Glass Jacobson Investment Advisors reported no remaining NeoGenomics position as of Q2 2025 after selling out during the quarter.
  • Glass Jacobson Investment Advisors sold 258 NeoGenomics shares in Q2 2025, an estimated $4.25K.
  • Glass Jacobson Investment Advisors first reported a position in NeoGenomics in Q4 2022 and held it in 9 quarters.
  • Glass Jacobson Investment Advisors's NeoGenomics position peaked at $4.25K in Q1 2025.
  • 274 funds tracked by Wall St. Rank held NeoGenomics as of Q2 2025.

Based on Glass Jacobson Investment Advisors's 13F filing for Q2 2025, filed 31 Jul 2025.